Angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and the risk of major adverse cardiac events in patients with diabetes and prior stroke: a …
CJ Shih, HT Chen, PW Chao, SC Kuo, SY Li… - Journal of …, 2016 - journals.lww.com
Objective: Renin–angiotensin–aldosterone system blockers are the preferred
antihypertensive medications in patients with diabetes and prior stroke. This study aimed to …
antihypertensive medications in patients with diabetes and prior stroke. This study aimed to …
Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on major adverse cardiac events in patients with newly …
CJ Shih, H Chu, SM Ou, YT Chen - International Journal of Cardiology, 2015 - Elsevier
Background Guidelines for hypertension management recommend either angiotensin-
converting enzyme inhibitors (ACEIs) or angiotensin II receptor blockers (ARBs) as first-line …
converting enzyme inhibitors (ACEIs) or angiotensin II receptor blockers (ARBs) as first-line …
Angiotensin receptor blockers (ARB) outperform angiotensin-converting enzyme (ACE) inhibitors on ischemic stroke prevention in patients with hypertension and …
Background Combination therapy with angiotensin-converting enzyme inhibitors (ACEI) and
angiotensin II receptor blockers (ARB) has been stressed for its comprehensive blocking of …
angiotensin II receptor blockers (ARB) has been stressed for its comprehensive blocking of …
Angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and diabetes: a meta-analysis of placebo-controlled clinical trials
Background To determine whether the administration of angiotensin-converting enzyme
(ACE) inhibitors or angiotensin II receptor blockers (ARBs) on top of standard cardiovascular …
(ACE) inhibitors or angiotensin II receptor blockers (ARBs) on top of standard cardiovascular …
Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on all-cause mortality, cardiovascular deaths, and cardiovascular events in …
J Cheng, W Zhang, X Zhang, F Han, X Li… - JAMA internal …, 2014 - jamanetwork.com
Importance Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor
blockers (ARBs) may have different effects on cardiovascular (CV) events in patients with …
blockers (ARBs) may have different effects on cardiovascular (CV) events in patients with …
Effects of ACEI/ARB in hypertensive patients with type 2 diabetes mellitus: a meta-analysis of randomized controlled studies
G Hao, Z Wang, R Guo, Z Chen, X Wang… - BMC cardiovascular …, 2014 - Springer
Background The effects of angiotensin-converting enzyme (ACE) inhibitors and angiotensin
II receptor blockers (ARBs) on cardiovascular (CV) risk in hypertensive patients with type 2 …
II receptor blockers (ARBs) on cardiovascular (CV) risk in hypertensive patients with type 2 …
A comparison between angiotensin converting enzyme inhibitors and angiotensin receptor blockers on end stage renal disease and major adverse cardiovascular …
LS Wu, SH Chang, GJ Chang, JR Liu, YH Chan… - Cardiovascular …, 2016 - Springer
Background Contemporary guidelines recommend angiotensin-converting-enzyme
inhibitors (ACEi) or angiotensin-receptor blockers (ARB) for hypertensive patients with …
inhibitors (ACEi) or angiotensin-receptor blockers (ARB) for hypertensive patients with …
The comparative effectiveness of angiotensin‐converting enzyme inhibitors and angiotensin II receptor blockers in patients with diabetes
The evidence examining the effect of angiotensin‐converting enzyme (ACE) inhibitors and
angiotensin receptor blockers (ARB s) on mortality in high‐risk patients is conflicting. To …
angiotensin receptor blockers (ARB s) on mortality in high‐risk patients is conflicting. To …
Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on prevention of stroke: Which one is better?
L Xiao, H Ouyang, Q Su… - International …, 2016 - internationaljournalofcardiology.com
We have read Pai's et al.[1] newly published paper with great interest, which using Taiwan's
National Health Insurance claims data, found that in the “real world” practice in patients with …
National Health Insurance claims data, found that in the “real world” practice in patients with …
A meta-analysis reporting effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients without heart failure
G Savarese, P Costanzo, JGF Cleland… - Journal of the American …, 2013 - jacc.org
Objectives: The goal of the study was to assess the effects of angiotensin-converting enzyme
inhibitors (ACE-Is) and angiotensin receptor blockers (ARBs) on the composite of …
inhibitors (ACE-Is) and angiotensin receptor blockers (ARBs) on the composite of …